Former Lexon UK director disqualified for role in nortriptyline competition law breach

A former director of Lexon UK has been disqualified for his involvement in the wholesaler’s “illegal information sharing” about the antidepressant nortriptyline, the Competition and Markets Authority (CMA) has announced.

Competition Markets Authority website
CMA: "This should be a message to all directors – if your company breaches competition law, you risk personal disqualification"

Latest from News

More from Business